永悦科技(603879.SH):傅文昌及其一致行動人付水法擬1.27億元合計轉讓5.99%股份
格隆匯6月19日丨永悦科技(603879.SH)公佈,公司收到持股5%以上非第一大股東傅文昌的通知,2023年6月19日,傅文昌及其一致行動人付水法與北京合易盈通資產管理有限公司——盈通豐澤三號私募證券投資基金簽署了《關於永悦科技股份有限公司之股份轉讓協議》,擬將其分別持有的1169萬股、991.72萬股無限售流通股份以協議轉讓方式轉讓給受讓方,轉讓價款為1.27億元,轉讓價格為5.89元/股。
協議轉讓之後,北京合易盈通資產管理有限公司——盈通豐澤三號私募證券投資基金將持有公司2160.72萬股,佔公司總股本的5.99%。本次協議轉讓不會觸發受讓方的要約收購義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.